Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment

NCT01146535 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza A Virus Infection

Interventions

DRUG: Interferon-alpha
DRUG: Oseltamivir
OTHER: maltose

Sponsor

Ainos, Inc. (f/k/a Amarillo Biosciences Inc.

Collaborators

[object Object]